Crossmark

The pharmacokinetics (PK) / pharmacodynamics (PD) of pretomanid, delamanid and bedaquiline in the BALB/c mouse model of central nervous system tuberculosis

Crossref DOI link: https://doi.org/10.1186/s12879-026-12813-w

Published Online: 2026-02-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhu, Hui

Ye, Yangxue

Fu, Lei

Zhang, Weiyan

Wang, Bin

Chen, Xi

Lu, Yu
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82173862)

Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support (ZYLX202123)
License Information

Text and Data Mining valid from 2026-02-12

Version of Record valid from 2026-03-23
More Information

Article History

Received: 22 May 2025

Accepted: 3 February 2026

First Online: 12 February 2026

Declarations

:

: The animal study was reviewed and approved by Animal Ethics Committee of the Beijing Chest Hospital-Affiliate of Capital Medical University.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below